Series B funding round for Medilink Therapeutics raising $70M in March 2022
Series B funding round for Medilink Therapeutics raising $70M in March 2022
| Investor | Firm Type | Partner |
|---|
LYFE CapitalLEAD | Venture Capital | — |
| Venture Capital | — | |
| Private Equity | — | |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$120M
Top Valuation
-
Medilink Therapeutics raised $70M in a Series B round.
The round was announced on 03/01/22.
The round was led by Qiming Venture Partners, LYFE Capital.